These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8059683)

  • 21. Pharmaceutical reimbursement: an overview.
    Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S4-10. PubMed ID: 18192246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Issues associated with the economic evaluation entitled "a cost-effectiveness evaluation of hospital discharge counseling by pharmacists".
    Le QA; Tang M
    J Pharm Pract; 2015 Jun; 28(3):234-5. PubMed ID: 25979904
    [No Abstract]   [Full Text] [Related]  

  • 23. Author response to "issues associated with the economic evaluation entitled "a cost-effectiveness evaluation of hospital discharge counseling by pharmacists".
    Chinthammit C; Armstrong EP; Warholak TL
    J Pharm Pract; 2015 Jun; 28(3):236-7. PubMed ID: 25979905
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacists' views of an experience in capitation reimbursement under the Iowa Medicaid drug program.
    Cirn JT
    Contemp Pharm Pract; 1980; 3(3):180-8. PubMed ID: 10297946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Getting Paid for Clinical Services.
    Martin CM
    Consult Pharm; 2018 May; 33(5):240-246. PubMed ID: 29789045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Part D resources for pharmacists.
    Armor BL
    J Pharm Pract; 2010 Apr; 23(2):144-5. PubMed ID: 21507808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current issues in pharmaceutical reimbursement.
    Fijalka S; Fye D; Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S11-26. PubMed ID: 18192243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the revenue cycle to promote growth of the pharmacy enterprise.
    O'Neal BC; Friemel AM; Glowczewski JE; Coggins JM; Macchia M; Forrey RA; Patel KR; Granko RP
    Am J Health Syst Pharm; 2018 Jun; 75(12):853-855. PubMed ID: 29880521
    [No Abstract]   [Full Text] [Related]  

  • 30. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacists, Medicare Part D, and the antikickback statute.
    Greene A
    Am J Health Syst Pharm; 2006 Aug; 63(15):1435-7. PubMed ID: 16849708
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative analysis of remuneration models for pharmaceutical professional services.
    Bernsten C; Andersson K; Gariepy Y; Simoens S
    Health Policy; 2010 Apr; 95(1):1-9. PubMed ID: 19945762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DUR by pharmacists--lessons learned for MTMS.
    Perrin PB
    Consult Pharm; 2006 Apr; 21(4):257; author reply 257. PubMed ID: 16676476
    [No Abstract]   [Full Text] [Related]  

  • 34. Compensation for cognitive services.
    Talley CR
    Am J Health Syst Pharm; 1995 Apr; 52(7):693. PubMed ID: 7627737
    [No Abstract]   [Full Text] [Related]  

  • 35. Death of pharmacy or safer dispensing?
    McNee W
    N Z Med J; 2003 May; 116(1174):U446. PubMed ID: 12766788
    [No Abstract]   [Full Text] [Related]  

  • 36. A cost-effectiveness evaluation of hospital discharge counseling by pharmacists.
    Chinthammit C; Armstrong EP; Warholak TL
    J Pharm Pract; 2012 Apr; 25(2):201-8. PubMed ID: 21987529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of reimbursement in a community hospital-based pharmacist-managed outpatient transition clinic.
    Huang J; Tattersall R; Morse K; Nickerson-Troy J; Clements E; Celauro L; Lovell A
    Am J Health Syst Pharm; 2017 Jun; 74(11 Supplement 2):S30-S34. PubMed ID: 28506974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathway to pharmacist medical provider status in Washington State.
    Hazlet TK; Karwaki TE; Downing DF
    J Am Pharm Assoc (2003); 2017; 57(1):116-119. PubMed ID: 27836482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reimbursement for nondispensing services--the critical issue.
    Soloway AH
    Am Pharm; 1979 Jun; 19(6):7. PubMed ID: 463742
    [No Abstract]   [Full Text] [Related]  

  • 40. Initiatives to control drug costs associated with an independent physician association.
    Abourjaily P; Kross J; Gouveia WA
    Am J Health Syst Pharm; 2003 Feb; 60(3):269-72. PubMed ID: 12613237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.